ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NICE rejects Sanofi's Cablivi in draft guidelines
June 16, 2020NICE has drawn up draft guidelines rejecting Sanofi's Cablivi (caplacizumab) for use alongside plasma exchange and immunosuppression for treating an acute episode of acquired thrombotic thrombocytopenic purpura (TTP). -
TTP spin-out to commercialise next-generation cell-sorting technology
April 11, 2019TTP has announced the formation of Cellular Highways Ltd. The new spin-out has been founded to commercialise TTP’s proprietary Vortex-Actuated Cell Sorting (VACS) technology -
TTP completes expansion of life sciences lab facility for Desktop Biology programmes
August 06, 2018Dedicated facility developed in response to increasing demand for product development projects in diagnostics, R&D and bioprocess.
Pharma Sources Insight January 2025
